ArticleNature communications2024
Tough double-bouligand architected concrete enabled by robotic additive manufacturing.
Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Bioinspired Mechanical Structures for Load Bearing and Energy Absorption: Cross-Scale Design and Fabrication Strategies.Biomimetics (Basel, Switzerland) · 2026Review
- Tough, thermal insulating and scalable puff pastry-inspired architected cementitious material via simple rolling-folding.Nature communications · 2026Article
- Tough, Ductile, and Strong Hard-Soft Cementitious Composite Enabled by Multi-Material Additive Manufacturing.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Generative adversarial networks enable biomimetic topology fusion with balanced mechanical performance and aesthetic quality.Scientific reports · 2026Article
- Machine learning guided resolution of mechanical trade-off in polymer composites via stress adaptive interface.Nature communications · 2026Article
- Cellulose nanofibers and limestone filler enable high-performance, sustainable, and cost-efficient printable concrete.Nature communications · 2026Article
- Real-time concrete strength monitoring using piezoelectric sensors and deep learning.Nature communications · 2025Article
- Machine learning-enabled inverse design of bioinspired layered composite structures with maximum auxetic performance.Communications engineering · 2025Article
- Development of novel filament production setup of continuous fiber reinforced composite filament for additive manufacturing applications.Scientific reports · 2025Article
- Gradient double-twisted Bouligand structural design for high impact resistance over a wide range of loading velocities.Science advances · 2025Article
- Tough Cortical Bone-Inspired Tubular Architected Cement-Based Material with Disorder.Advanced materials (Deerfield Beach, Fla.) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Nature has developed numerous design motifs by arranging modest materials into complex architectures. The damage-tolerant, double-bouligand architecture found in the coelacanth fish scale is comprised of collagen fibrils helically arranged in a bilayer manner. Here, we exploit the toughening mechanisms of double-bouligand designs by engineering architected concrete using a large-scale two-component robotic additive manufacturing process. The process enables intricate fabrication of the architected concrete components at large-scale. The double-bouligand designs are benchmarked against bouligand and conventional rectilinear counterparts and monolithic casts. In contrast to cast concrete, double-bouligand design demonstrates a non-brittle response and a rising R-curve, due to a hypothesized bilayer crack shielding mechanism. In addition, interlocking behind and crack deflection ahead of the crack tip in bilayer double-bouligand architected concrete elicits a 63% increase in fracture toughness compared to cast counterparts.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.